Skip Navigation
 
 
Printable Version

NADA Number: 100-854

Proprietary Name Fura Ointment
Sponsor Farnam Companies, Inc.
Sponsor Address 301 West Osborn
Phoenix, AZ    85013-3928
USA
Ingredients Nitrofurazone
Species (Class) DOGS (Dog, no use class stated or implied)
EQUIDS (Horse, not for meat production)
Routes of Administration Topical
Dosage Form Ointment
Dispensing Status OTC
Dosage Amount,
Indications
& Limitations

524.1580b Nitrofurazone ointment.

Specifications: The drug contains 0.2 percent nitrofurazone in a water-soluble base.

Conditions of use:

Dogs

Amount: Apply directly on the lesion with a spatula or first place on a piece of gauze. Use of a bandage is optional. The preparation should remain on the lesion for at least 24 hours. The dressing may be changed several times daily or left on the lesion for a longer period.

Indications: For prevention or treatment of surface bacterial infections of wounds, burns, and cutaneous ulcers of dogs or horses.

Limitations. In case of deep or puncture wounds or serious burns, use only as recommended by veterinarian. If redness irritation, or swelling persists or increases, discontinue use. Consult veterinarian.

Horses

Amount: Apply directly on the lesion with a spatula or first place on a piece of gauze. Use of a bandage is optional. The preparation should remain on the lesion for at least 24 hours. The dressing may be changed several times daily or left on the lesion for a longer period.

Indications: For prevention or treatment of surface bacterial infections of wounds, burns, and cutaneous ulcers of dogs or horses.

Limitations. Not for use in horses intended for food. In case of deep or puncture wounds or serious burns, use only as recommended by veterinarian. If redness irritation, or swelling persists or increases, discontinue use. Consult veterinarian.

NAS/NRC status: These conditions are NAS/NRC reviewed and found effective. Applications for these uses need not include effectiveness data as specified by 514.111 of this chapter, but may require bioequivalency and safety information.